Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.
Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, Selim H, Rubin P, Ortiz H. Cox JD, et al. Among authors: pajak tf. Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1191-5. doi: 10.1016/0360-3016(91)90227-u. Int J Radiat Oncol Biol Phys. 1991. PMID: 2045293 Clinical Trial.
Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313.
Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, Selim HM, Byhardt RW, Rubin P, Ortiz HG, et al. Cox JD, et al. Among authors: pajak tf. Cancer. 1992 Jun 1;69(11):2744-8. doi: 10.1002/1097-0142(19920601)69:11<2744::aid-cncr2820691119>3.0.co;2-u. Cancer. 1992. PMID: 1571904 Clinical Trial.
Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
Cox JD, Pajak TF, Marcial VA, Hanks GE, Mohiuddin M, Fu KK, Byhardt RW, Rubin P. Cox JD, et al. Among authors: pajak tf. Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):515-21. doi: 10.1016/0360-3016(90)90054-n. Int J Radiat Oncol Biol Phys. 1990. PMID: 2180866 Clinical Trial.
Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG).
Marcial VA, Pajak TF, Chang C, Tupchong L, Stetz J. Marcial VA, et al. Among authors: pajak tf. Int J Radiat Oncol Biol Phys. 1987 Jan;13(1):41-7. doi: 10.1016/0360-3016(87)90258-6. Int J Radiat Oncol Biol Phys. 1987. PMID: 3542916 Clinical Trial.
Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials.
Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, Emami B, Roach M 3rd. Cox JD, et al. Among authors: pajak tf. Int J Radiat Oncol Biol Phys. 1993 Oct 20;27(3):493-8. doi: 10.1016/0360-3016(93)90371-2. Int J Radiat Oncol Biol Phys. 1993. PMID: 8226140 Clinical Trial.
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK; Radiation Therapy Oncology Group. Machtay M, et al. Among authors: pajak tf. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1008-17. doi: 10.1016/j.ijrobp.2007.04.063. Epub 2007 Aug 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17716826 Clinical Trial.
176 results